TipRanks
BeOne Medicines (DE:49BA)
FRANKFURT:49BA

Compare BeOne Medicines (49BA) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
BeOne Medicines
€318.00
€35.73B
26.34
8.90%
14 Buy
0 Hold
0 Sell
Strong Buy
Exelixis
$56.72
$14.47B
17.89
46.79%
3 Buy
9 Hold
1 Sell
Hold
Incyte
$128.12
$23.37B
14.04
31.41%
11 Buy
10 Hold
0 Sell
Moderate Buy
Summit Therapeutics
$14.23
$13.37B
-15.42
-19.41%
10 Buy
6 Hold
0 Sell
Moderate Buy
Zai Lab
$26.82
$2.84B
-13.94
-24.09%
3 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$34.36
$20.25B
27.87
14.66%
9 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:49BA
BeOne Medicines
318.00
28.00
9.66%
EXEL
Exelixis
58.85
18.84
47.09%
INCY
Incyte
114.13
26.90
30.84%
SMMT
Summit Therapeutics
17.27
-4.88
-22.03%
ZLAB
Zai Lab
25.62
-7.69
-23.09%
GMAB
Genmab
38.48
5.17
15.52%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts